Eledon Pharmaceuticals Inc. buy Guggenheim
Start price
28.01.25
/
50%
€4.54
Target price
28.01.26
€8.63
Performance (%)
-51.10%
Price
28.08.25
€2.16
Summary
This prediction is currently active. Massive losses of -51.10% have been the result for the BUY prediction by Guggenheim. This prediction currently runs until 28.01.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eledon Pharmaceuticals Inc. | 0.000% | 0.000% |
| iShares Core DAX® | -1.740% | -1.152% |
| iShares Nasdaq 100 | -0.157% | -0.813% |
| iShares Nikkei 225® | -1.705% | 3.309% |
| iShares S&P 500 | 0.148% | 0.240% |
Comments by Guggenheim for this prediction
In the thread Eledon Pharmaceuticals Inc. diskutieren
Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) is now covered by analysts at Guggenheim. They set a "buy" rating and a $9.00 price target on the stock.
Ratings data for ELDN provided by MarketBeat